Involvement of multiple PKC isoforms in phorbol 12,13-dibutyrate-induced contraction during high K(+) depolarization in bronchial smooth muscle of mice. 2010

Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
Department of Pharmacology, School of Pharmacy, Hoshi University, Shinagawa-ku, Tokyo, Japan. sakai@hoshi.ac.jp

In airway smooth muscle, protein kinase C (PKC) has been implicated in a number of functional responses including the regulation of contractility. However, the exact role of PKC on bronchial smooth muscle (BSM) contraction is still unclear. In the present study, to determine the role of PKC activation in the BSM contraction, the effects of phorbol 12,13-dibutyrate (PDBu, a direct PKC activator) on BSM tone were examined in the absence and presence of K(+)-induced depolarization stimulation. The force development was not evoked by treatment with 1 µM PDBu alone. However, a strong contraction was induced by PDBu during high K(+) contraction. The contraction induced by PDBu during high K(+) stimulation was significantly abolished by pretreatment with nicardipine, an L-type voltage dependent Ca(2+) channel blocker. In RT-PCR analysis, mRNAs of PKCα, β, γ, δ, ε, η and θ isoforms were detected in mouse BSM. Gö6976 (an inhibitor of PKCs α and β) and rottlerin (an inhibitor of PKCδ) significantly but partially inhibited the PDBu-induced BSM contraction during K(+) stimulation. GF109203X (an inhibitor of PKCs α, β, γ, and ε) completely inhibited the PDBu-induced contraction during K(+) stimulation. In conclusion, it is suggested that the PDBu-induced BSM contraction is dependent on an increase in cytosolic Ca(2+). Furthermore, it is possible that both cPKC and nPKC(s) participate in the PDBu-induced contraction of mouse BSM during K(+) stimulation.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009129 Muscle Tonus The state of activity or tension of a muscle beyond that related to its physical properties, that is, its active resistance to stretch. In skeletal muscle, tonus is dependent upon efferent innervation. (Stedman, 25th ed) Muscle Tension,Muscle Tightness,Muscular Tension,Tension, Muscle,Tension, Muscular,Tightness, Muscle,Tonus, Muscle
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor

Related Publications

Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
August 1987, European journal of pharmacology,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
January 2012, Frontiers in pharmacology,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
September 1993, Pharmacology,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
November 1991, British journal of pharmacology,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
July 1996, European journal of pharmacology,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
June 2001, American journal of physiology. Gastrointestinal and liver physiology,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
April 2005, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
December 1987, The Journal of pharmacology and experimental therapeutics,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
August 2009, Acta pharmacologica Sinica,
Hiroyasu Sakai, and Yusuke Kurihara, and Yuki Hashimoto, and Yoshihiko Chiba, and Miwa Misawa
December 1988, European journal of pharmacology,
Copied contents to your clipboard!